Peak Bio, Inc.
DelistedCIK 1834645fmd_06YXZ7GSDMXQCSFX18EQMQ715PManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2021 to Sep 30, 2024, 15 periods
Latest annual · FY2023
Millions- Total revenues
- 0
- Operating income
- (13)
- Net income
- (13)
- Free cash flow
- (5)
Latest quarter · Q3 FY2024
Millions- Total revenues
- 0
- Operating income
- (1)
- Net income
- 2
Peak Bio, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $367,877 | $607,681 | -39.5% | 10-K 2024-08-06 · proof |
| Operating income | -$13.1 million | -$11.8 million | 10-K 2024-08-06 · proof | |
| Net income | -$12.8 million | -$13.1 million | 10-K 2024-08-06 · proof | |
| Cash from operating activities | -$4.8 million | -$7.5 million | 10-K 2024-08-06 · proof | |
| Free cash flow | -$4.8 million | -$7.6 million | 10-K 2024-08-06 · proof | |
| Total assets | $2.6 million | $7.5 million | -65.5% | 10-K 2024-08-06 · proof |
| Total liabilities | $20.8 million | $15.6 million | +32.8% | 10-K 2024-08-06 · proof |
| Cash and cash equivalents | $381,649 | $654,892 | -41.7% | 10-K 2024-08-06 · proof |
- What was Peak Bio, Inc.'s revenue in fiscal 2023?
- Peak Bio, Inc. reported revenue of $367,877 for fiscal 2023 (the year ended Dec 31, 2023), against $607,681 the year before (-39.5%). Source: the 10-K filed with the SEC on Aug 6, 2024. SEC
- What was Peak Bio, Inc.'s operating income in fiscal 2023?
- Peak Bio, Inc. reported operating income of -$13.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$11.8 million the year before. Source: the 10-K filed with the SEC on Aug 6, 2024. SEC
- What was Peak Bio, Inc.'s net income in fiscal 2023?
- Peak Bio, Inc. reported net income of -$12.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$13.1 million the year before. Source: the 10-K filed with the SEC on Aug 6, 2024. SEC
- What was Peak Bio, Inc.'s cash from operating activities in fiscal 2023?
- Peak Bio, Inc. reported cash from operating activities of -$4.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$7.5 million the year before. Source: the 10-K filed with the SEC on Aug 6, 2024. SEC
- What was Peak Bio, Inc.'s free cash flow in fiscal 2023?
- Peak Bio, Inc. reported free cash flow of -$4.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$7.6 million the year before. Source: the 10-K filed with the SEC on Aug 6, 2024. SEC
- What are Peak Bio, Inc.'s total assets?
- As of Dec 31, 2023, Peak Bio, Inc. reported total assets of $2.6 million, against $7.5 million a year earlier (-65.5%). Source: the 10-K filed with the SEC on Aug 6, 2024. SEC
- What are Peak Bio, Inc.'s total liabilities?
- As of Dec 31, 2023, Peak Bio, Inc. reported total liabilities of $20.8 million, against $15.6 million a year earlier (+32.8%). Source: the 10-K filed with the SEC on Aug 6, 2024. SEC
- What are Peak Bio, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Peak Bio, Inc. reported cash and cash equivalents of $381,649, against $654,892 a year earlier (-41.7%). Source: the 10-K filed with the SEC on Aug 6, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1834645&period_type=annual&limit=5"Information only, not investment advice.